Over the past 12 months, 2 insiders at SOLENO THERAPEUTICS INC filed 6 open-market SEC Form 4 transactions on SLNO: 0 purchases worth $0 and 6 sales worth $429K. Insiders have been net sellers over this period. The most recent filing was on Mar 27, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 27, 26 | Michael F. HuangSr. VP of Clinical Development | SELL | 4.3K | $31.72 | $128K |
| Mar 27, 26 | Meredith ManningChief Commercial Officer | SELL | 4.9K | $31.72 | $146K |
| Jul 1, 25 | Patricia C HiranoSEE REMARKS | SELL | 3.8K | $82.76 | $317K |
| Jun 24, 25 | Patricia C HiranoSEE REMARKS | SELL | 266 | $84.25 | $22K |
| Apr 1, 25 | Patricia C HiranoSEE REMARKS | SELL | 3.8K | $70.11 | $265K |
| Mar 28, 25 | Matthew PaulsDirector | SELL | 5.9K | $71.55 | $425K |
| Mar 28, 25 | Patricia C HiranoSEE REMARKS | SELL | 12.3K | $73.60 | $849K |
| Mar 28, 25 | Vivo Opportunity Fund Holdings, L.p.TenPercentOwner | SELL | 333.6K | $70.60 | $23.5M |
| Mar 27, 25 | Bhatnagar AnishCHIEF EXECUTIVE OFFICER | SELL | 209.7K | $72.64 | $13.9M |
| Mar 27, 25 | Patricia C HiranoSEE REMARKS | SELL | 46.2K | $72.64 | $3.1M |
| Mar 27, 25 | Michael F. HuangSr. VP of Clinical Development | SELL | 10.0K | $72.64 | $700K |
| Mar 27, 25 | James H MackanessCHIEF FINANCIAL OFFICER | SELL | 36.2K | $72.64 | $2.5M |
| Mar 27, 25 | Meredith ManningChief Commercial Officer | SELL | 37.0K | $72.64 | $2.5M |
| Mar 27, 25 | Kristen YenSEE REMARKS | SELL | 50.2K | $72.64 | $3.3M |
| Mar 27, 25 | Vivo Opportunity Fund Holdings, L.p.TenPercentOwner | SELL | 1.10M | $67.80 | $74.6M |
| Mar 26, 25 | Vivo Opportunity Fund Holdings, L.p.TenPercentOwner | SELL | 400.0K | $65.80 | $26.3M |
| Jan 3, 25 | Bhatnagar AnishCHIEF EXECUTIVE OFFICER | SELL | 10.2K | $46.18 | $469K |
| Jan 3, 25 | Patricia C HiranoSEE REMARKS | SELL | 1.5K | $46.18 | $67K |
| Jan 3, 25 | James H MackanessCHIEF FINANCIAL OFFICER | SELL | 3.8K | $46.18 | $175K |
| Jan 3, 25 | Kristen YenSEE REMARKS | SELL | 2.3K | $46.18 | $108K |
| Jan 2, 25 | Bhatnagar AnishCHIEF EXECUTIVE OFFICER | SELL | 10.1K | $45.92 | $457K |
| Jan 2, 25 | Patricia C HiranoSEE REMARKS | SELL | 1.4K | $45.92 | $66K |
| Jan 2, 25 | James H MackanessCHIEF FINANCIAL OFFICER | SELL | 3.8K | $45.92 | $171K |
| Jan 2, 25 | Kristen YenSEE REMARKS | SELL | 2.3K | $45.92 | $105K |
| Oct 1, 24 | Bhatnagar AnishCHIEF EXECUTIVE OFFICER | SELL | 19.4K | $50.25 | $958K |
| Oct 1, 24 | Patricia C HiranoSEE REMARKS | SELL | 2.8K | $50.25 | $138K |
| Oct 1, 24 | James H MackanessCHIEF FINANCIAL OFFICER | SELL | 7.2K | $50.25 | $358K |
| Oct 1, 24 | Kristen YenSEE REMARKS | SELL | 2.8K | $50.25 | $138K |
| Aug 29, 24 | Bhatnagar AnishCHIEF EXECUTIVE OFFICER | SELL | 47.6K | $47.83 | $2.2M |
| Aug 29, 24 | Patricia C HiranoSEE REMARKS | SELL | 4.4K | $47.83 | $209K |
| Aug 29, 24 | James H MackanessCHIEF FINANCIAL OFFICER | SELL | 5.6K | $47.83 | $264K |
| Aug 29, 24 | Kristen YenSEE REMARKS | SELL | 4.4K | $47.83 | $209K |
| Aug 29, 24 | Vivo Opportunity, LlcTenPercentOwner | SELL | 100.0K | $47.22 | $4.7M |
| Aug 28, 24 | Bhatnagar AnishCHIEF EXECUTIVE OFFICER | SELL | 30.3K | $48.03 | $1.4M |
| Aug 28, 24 | Patricia C HiranoSEE REMARKS | SELL | 2.8K | $48.03 | $133K |
| Aug 28, 24 | James H MackanessCHIEF FINANCIAL OFFICER | SELL | 3.6K | $48.03 | $168K |
| Aug 28, 24 | Kristen YenSEE REMARKS | SELL | 2.8K | $48.03 | $133K |
| Aug 28, 24 | Vivo Opportunity, LlcTenPercentOwner | SELL | 425.0K | $47.35 | $20.1M |
| Aug 27, 24 | Vivo Opportunity, LlcTenPercentOwner | SELL | 500.0K | $48.73 | $24.4M |
| Aug 6, 24 | Bhatnagar AnishCHIEF EXECUTIVE OFFICER | SELL | 39.4K | $45.89 | $1.8M |
| Aug 6, 24 | Patricia C HiranoSEE REMARKS | SELL | 3.4K | $45.89 | $156K |
| Aug 6, 24 | James H MackanessCHIEF FINANCIAL OFFICER | SELL | 4.6K | $45.89 | $213K |
| Aug 6, 24 | Kristen YenSEE REMARKS | SELL | 3.4K | $45.89 | $156K |
| Aug 5, 24 | Bhatnagar AnishCHIEF EXECUTIVE OFFICER | SELL | 32.8K | $46.14 | $1.5M |
| Aug 5, 24 | Patricia C HiranoSEE REMARKS | SELL | 2.8K | $46.14 | $129K |
| Aug 5, 24 | James H MackanessCHIEF FINANCIAL OFFICER | SELL | 3.9K | $46.14 | $175K |
| Aug 5, 24 | Kristen YenSEE REMARKS | SELL | 2.8K | $46.14 | $129K |
| Jul 1, 24 | Bhatnagar AnishCHIEF EXECUTIVE OFFICER | SELL | 15.1K | $41.63 | $627K |
| Jul 1, 24 | Patricia C HiranoSEE REMARKS | SELL | 1.7K | $41.63 | $71K |
| Jul 1, 24 | James H MackanessCHIEF FINANCIAL OFFICER | SELL | 5.6K | $41.63 | $234K |
Over the past 12 months, insiders at SOLENO THERAPEUTICS INC filed 0 open-market purchases worth $0 and 6 sales worth $429K on SLNO, which makes them net sellers over the period. The most recent Form 4 was filed on Mar 27, 26.
2 different insiders at SOLENO THERAPEUTICS INC filed open-market SEC Form 4 transactions on SLNO over the last 12 months.
InsiderTape plots every SLNO insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every SOLENO THERAPEUTICS INC insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →